Digital Mammographic Imaging Screening Trial

The Digital Mammographic Imaging Screening Trial (DMIST), is a multi-institutional research study on the efficacy for screening of Full Field digital mammography compared to conventional film-screen mammography that was sponsored by the U.S. National Cancer Institute and performed by ACRIN.

The findings^[1][2] that FFDM was not inferior to the existing technology, and potentially superior in younger women with dense breasts, has led to a rapid proliferation of digital systems in the US.

References

1. ^ Pisano (27 Oct 2005). "Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening". NEJM. http://content.nejm.org/cgi/content/full/353/17/1773. Retrieved 11 Feb 2010. 
2. ^ Berry (27 Oct 2005). "Film or Digital Mammographic Screening?". NEJM. http://content.nejm.org/cgi/content/full/353/17/1846. Retrieved 11 Feb 2010. 

External links

• Digital Mammographic Imaging Screening Trial - National Cancer Institute
• ACRIN-6652